Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action

Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action

Giulia Abate, Maurizio Memo, Daniela Uberti

In the middle of the coronavirus disease 19 (COVID-19) outbreak, the main efforts of the scientific community are rightly all focused on identifying efficient pharmacological treatments to cure the acute severe symptoms and developing a reliable vaccine. On the other hand, we cannot exclude that, in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) positive subjects, the virus infection could have long-term consequences, leading to chronic medical conditions such as dementia and neurodegenerative disease. Considering the age of SARS-CoV-2 infected subjects, the neuroinvasive potential might lead/contribute to the development of neurodegenerative diseases. Here, we analyzed a possible link between SARS-CoV-2 infection and Alzheimer’s disease risk, hypothesizing possible mechanisms at the base of disease development. This reflection raises the need to start to experimentally investigating today the mechanistic link between Alzheimer’s disease (AD) and COVID-19 to be ready tomorrow.

2020

sars-cov-2 infection, ACE2, neuroinvasivness, Alzheimer’s disease risk

10.3390/healthcare8030286

Epidemiology and Health

Korean Society of Epidemiology

Medicine